Newmed Energy LP banner
N

Newmed Energy LP
OTC:DKDRF

Watchlist Manager
Newmed Energy LP
OTC:DKDRF
Watchlist
Price: 6.82 USD 2.1% Market Closed
Market Cap: $8B

EV/EBITDA

13.2
Current
93%
More Expensive
vs 3-y median of 6.8

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
13.2
=
Enterprise Value
$9.4B
/
EBITDA
$697.7m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
13.2
=
Enterprise Value
$9.4B
/
EBITDA
$697.7m

Valuation Scenarios

Newmed Energy LP is trading above its 3-year average

If EV/EBITDA returns to its 3-Year Average (6.8), the stock would be worth $3.54 (48% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-75%
Maximum Upside
No Upside Scenarios
Average Downside
45%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 13.2 $6.82
0%
3-Year Average 6.8 $3.54
-48%
5-Year Average 6.5 $3.35
-51%
Industry Average 3.2 $1.68
-75%
Country Average 12.7 $6.57
-4%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$9.4B
/
Oct 2025
$697.7m
=
13.2
Current
$9.4B
/
Dec 2025
$2.2B
=
4.3
Forward
$9.4B
/
Dec 2026
$2.8B
=
3.3
Forward
$9.4B
/
Dec 2027
$2.9B
=
3.2
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close

Market Distribution

In line with most companies in Israel
Percentile
51st
Based on 409 companies
51st percentile
13.2
Low
0 — 7.2
Typical Range
7.2 — 21.8
High
21.8 —
Distribution Statistics
Israel
Min 0
30th Percentile 7.2
Median 12.7
70th Percentile 21.8
Max 361.2

Newmed Energy LP
Glance View

Market Cap
8B USD
Industry
Energy

NewMed Energy LP, once known under the banner of Delek Drilling, is a powerhouse in the Israeli energy sector, particularly noted for its pivotal role in the exploration and production of natural gas. Nestled in the vibrant hub of the Eastern Mediterranean, the company is woven into the fabric of one of the most significant natural gas finds in recent history—the Leviathan and Tamar fields. This dynamic firm, leveraging its seasoned expertise, taps into the burgeoning demand for natural gas, both in domestic markets and across international borders. By prioritizing advanced extraction technologies and strategic partnerships, NewMed Energy has carved out a robust pipeline of operations that fortify its strategic position in this competitive arena. The lifeblood of NewMed Energy's business model lies in its ability to masterfully orchestrate the complex supply chain of natural gas. From the seismic surveys and exploratory drilling phases to the eventual extraction and distribution, the company orchestrates an intricate ballet of operational excellence. NewMed Energy earns its revenues primarily through the sale of extracted natural gas, engaging in long-term sales agreements with power plants, industrial customers, and neighboring countries, thereby ensuring a stable cash flow. This strategic foresight not only accommodates the increasing energy requirements of its clientele but also aligns the company with global trends favoring cleaner energy solutions. Through its savvy exploitation of the region's geological bounty, NewMed Energy LP has established itself as a cornerstone of energy supply in the Eastern Mediterranean, underpinning its growth with a commitment to sustainability and innovation.

DKDRF Intrinsic Value
19.18 USD
Undervaluation 64%
Intrinsic Value
Price $6.82
N
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett